Axcelis Technologies Inc.

Axcelis Technologies designs, manufactures and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. The company also provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services and customer training. The company provides high energy, high current and medium current implanters for all application requirements. The company's Purion systems are all based on a common platform which enables a combination of implant purity, precision and productivity by combining a single wafer end station, with a spot beam architecture. The company's other products include curing systems, and thermal processing systems.
  • TickerACLS
  • ISINUS0545402085
  • ExchangeNASDAQ Stock Market
  • SectorTechnology Hardware & Equipment
  • CountryUnited States

Axcelis Technologies Inc: 2 directors sold after exercising options/sold

Two Directors at Axcelis Technologies Inc sold after exercising options/sold 85,529 shares at between 39.270USD and 39.390USD. The significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading ac...

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Status Quo: Bullish Outlook Intact Our outlook remains status quo: we are bullish and we believe the path of least resistance remains higher. With a lack of breakdowns across Sectors and major indexes, small- and mid-caps outperforming, and new price highs in the S&P 500, Nasdaq 100, Technology, and Discretionary, it is hard to be anything but bullish. · Sector Relative Strength Rankings & Weighting Recommendations. A portion of our bullish outlook has been supported by the fact that RS for defensive Sectors is making lower highs ever since the S&P 500 bottomed in March. This contin...

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

S&P 500 Testing Key Resistance As we have outlined in recent weeks, our base case continues to be for near-term consolidation while the market is in a “wait-and-see” phase as it relates to states re-opening. The S&P 500 is again testing key resistance at the 61.8% Fibonacci retracement level of 2934.49 and also the 2950-3000 level we previously identified. We continue to have concerns that lead us to believe the market is not yet out of the woods, however these concerns are counterbalanced by a number of positive developments. When it comes down to it, key support levels mentioned last we...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A number of names in the Communications Sector are showing signs of leadership. (ex. GLUU, TWTR, GOOGL, NYT, and NWSA) • Consumer Discretionary continues to have a number of attractive names technically. (ex. TPR, LGIH, DHI, VSTO, RGR, PENN, SGMS, BYD, BJRI, BKE, EBAY, SIG, HAIN, and ENR ) • A number of Financial Sector names appear to be perking up. (ex. JHG, INTL, EVR, GHL, ARR, and CINF)

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Energy Sector names continue to develop price and RS reversals. (ex. OXY, VAL, DO, RIG, SLB, MTDR, SM, MUR, WPX, XEC, JAG, TALO, APA, DVN, and EOG) • Aero-Defense related names are reversing price and RS downtrends. (ex. AVAV, NOC, AJRD, LMT, LHX, HII, and RTN.

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A number of names in the Communications Sector are showing signs of leadership. (ex. GLUU, TWTR, GOOGL, NYT, and NWSA) • Consumer Discretionary continues to have a number of attractive names technically. (ex. TPR, LGIH, DHI, VSTO, RGR, PENN, SGMS, BYD, BJRI, BKE, EBAY, SIG, HAIN, and ENR ) • A number of Financial Sector names appear to be perking up. (ex. JHG, INTL, EVR, GHL, ARR, and CINF)

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Energy Sector names continue to develop price and RS reversals. (ex. OXY, VAL, DO, RIG, SLB, MTDR, SM, MUR, WPX, XEC, JAG, TALO, APA, DVN, and EOG) • Aero-Defense related names are reversing price and RS downtrends. (ex. AVAV, NOC, AJRD, LMT, LHX, HII, and RTN.

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A number of significant Communications names are developing bullishly. (ex. GOOG, FB, and NWS) • Consumer Discretionary names continue to develop positively. (ex. THRM, LEA, WYNN, PENN, CMG, KMX, and AMZN) • Energy Sector names continue to attempt to carve out bottoms. (ex. OXY, VAL) • Financial Sector names continue to develop bullishly (ex. C, UMPQ, EWBC, TROW, MSCI, SPGI, GS, and MS)

Dave Nicoski ...
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Axcelis Technologies Inc: 2 directors sold after exercising options/sold

Two Directors at Axcelis Technologies Inc sold after exercising options/sold 85,529 shares at between 39.270USD and 39.390USD. The significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading ac...

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Status Quo: Bullish Outlook Intact Our outlook remains status quo: we are bullish and we believe the path of least resistance remains higher. With a lack of breakdowns across Sectors and major indexes, small- and mid-caps outperforming, and new price highs in the S&P 500, Nasdaq 100, Technology, and Discretionary, it is hard to be anything but bullish. · Sector Relative Strength Rankings & Weighting Recommendations. A portion of our bullish outlook has been supported by the fact that RS for defensive Sectors is making lower highs ever since the S&P 500 bottomed in March. This contin...

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

S&P 500 Testing Key Resistance As we have outlined in recent weeks, our base case continues to be for near-term consolidation while the market is in a “wait-and-see” phase as it relates to states re-opening. The S&P 500 is again testing key resistance at the 61.8% Fibonacci retracement level of 2934.49 and also the 2950-3000 level we previously identified. We continue to have concerns that lead us to believe the market is not yet out of the woods, however these concerns are counterbalanced by a number of positive developments. When it comes down to it, key support levels mentioned last we...

Delphine Chauvin

Elis : Issuance Focus

Elis is looking to return to the bond market to refinance the last part of its acquisition loan (around € 1bn). The group plans to place two tranches, a benchmark-size five-year tranche (February 2023) and an eight-year tranche of € 300m (February 2026).We are adopting a Positive Credit Opinion on the issuer. Elis appears to be a strong "BB" issuer, enjoying a fairly resilient business model thanks to management’s prudent financial strategy (respect of a given debt ratio target, growth strategy via targeted acquisitions and shareholders’ contribution when financing larger deals). Addit...

Delphine Chauvin

Elis : Focus Emission

Elis souhaite revenir sur le marché obligataire pour refinancer la dernière partie de son crédit d’acquisition (environ 1 md EUR). Le groupe envisage de placer deux tranches, l’une de taille « benchmark » à 5 ans (février 2023) et l’autre de 300 m EUR à 8 ans (février 2026).Nous avons une opinion crédit plutôt Positive sur la signature. Elis nous apparaît comme un solide émetteur « BB », avec un business model résilient et un management qui conserve une gestion financière prudente (respect de l’objectif de ratio d’endettement donné, stratégie de croissance par ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch